CliffBio
small molecule

DENDRID

IDOXURIDINE

Loss of exclusivity—loss of exclusivity
CompanyAlcon →See this company's full patent-cliff portfolio

Drug detail

Brand nameDENDRID
Active ingredientIDOXURIDINE
Strength0.1%
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
Marketing statusDISCN

More from Alcon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

DENDRID patent cliff — loss of exclusivity — | CliffBio